/

/

Biotech Firm Makes Trip-Free Psilocybin Drug to Treat Dementia

Tue, Sep 10

To many, creating a “trip-free” psychedelic drug is an oxymoron and another attempt to sanitize culture for profit. But could a trip-free psychedelic drug be the key to treating dementia? Our latest: https://t.co/KqovtTUYlK

7381

Psilera is laying the groundwork for future FDA approval of its trip-free psychedelic drug that could potentially treat a common form of dementia.

Discover